Point-Of-Care Molecular Diagnostics Market Size, Share & Growth Graph by 2034

Table Of Content

Executive Summary

Research Scope & Segmentation

Research Objectives
Limitations & Assumptions
Market Scope & Segmentation
Currency & Pricing Considered

Market Opportunity Assessment

Emerging Regions / Countries
Emerging Companies
Emerging Applications / End Use

Market Trends

Drivers
Market Warning Factors
Latest Macro Economic Indicators
Geopolitical Impact
Technology Factors

Market Assessment

Porters Five Forces Analysis
Value Chain Analysis

Regulatory Framework

North America
Europe
APAC
Middle East and Africa
LATAM

ESG Trends

Global Point-Of-Care Molecular Diagnostics Market Size Analysis

Global Point-Of-Care Molecular Diagnostics Market Introduction
By Product Type
1. Introduction
  1. Product Type By Value
2. Analyzers
  1. By Value
3. Test Kits
  1. By Value
4. Reagents
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. PCR
  1. By Value
3. Genetic Sequencing
  1. By Value
4. Hybridization
  1. By Value
5. Microarray
  1. By Value
By End User
1. Introduction
  1. End User By Value
2. Decentralized Laboratories
  1. By Value
3. Hospital
  1. By Value
4. Homecare
  1. By Value
5. Assisted Living Healthcare Facilities
  1. By Value

North America Market Analysis

Introduction
By Product Type
1. Introduction
  1. Product Type By Value
2. Analyzers
  1. By Value
3. Test Kits
  1. By Value
4. Reagents
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. PCR
  1. By Value
3. Genetic Sequencing
  1. By Value
4. Hybridization
  1. By Value
5. Microarray
  1. By Value
By End User
1. Introduction
  1. End User By Value
2. Decentralized Laboratories
  1. By Value
3. Hospital
  1. By Value
4. Homecare
  1. By Value
5. Assisted Living Healthcare Facilities
  1. By Value
U.S.
1. By Product Type
  1. Introduction
    1. Product Type By Value
  2. Analyzers
    1. By Value
  3. Test Kits
    1. By Value
  4. Reagents
    1. By Value
2. By Technology
  1. Introduction
    1. Technology By Value
  2. PCR
    1. By Value
  3. Genetic Sequencing
    1. By Value
  4. Hybridization
    1. By Value
  5. Microarray
    1. By Value
3. By End User
  1. Introduction
    1. End User By Value
  2. Decentralized Laboratories
    1. By Value
  3. Hospital
    1. By Value
  4. Homecare
    1. By Value
  5. Assisted Living Healthcare Facilities
    1. By Value
Canada

Europe Market Analysis

Introduction
By Product Type
1. Introduction
  1. Product Type By Value
2. Analyzers
  1. By Value
3. Test Kits
  1. By Value
4. Reagents
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. PCR
  1. By Value
3. Genetic Sequencing
  1. By Value
4. Hybridization
  1. By Value
5. Microarray
  1. By Value
By End User
1. Introduction
  1. End User By Value
2. Decentralized Laboratories
  1. By Value
3. Hospital
  1. By Value
4. Homecare
  1. By Value
5. Assisted Living Healthcare Facilities
  1. By Value
U.K.
1. By Product Type
  1. Introduction
    1. Product Type By Value
  2. Analyzers
    1. By Value
  3. Test Kits
    1. By Value
  4. Reagents
    1. By Value
2. By Technology
  1. Introduction
    1. Technology By Value
  2. PCR
    1. By Value
  3. Genetic Sequencing
    1. By Value
  4. Hybridization
    1. By Value
  5. Microarray
    1. By Value
3. By End User
  1. Introduction
    1. End User By Value
  2. Decentralized Laboratories
    1. By Value
  3. Hospital
    1. By Value
  4. Homecare
    1. By Value
  5. Assisted Living Healthcare Facilities
    1. By Value
Germany
France
Spain
Italy
Russia
Nordic
Benelux
Rest of Europe

APAC Market Analysis

Introduction
By Product Type
1. Introduction
  1. Product Type By Value
2. Analyzers
  1. By Value
3. Test Kits
  1. By Value
4. Reagents
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. PCR
  1. By Value
3. Genetic Sequencing
  1. By Value
4. Hybridization
  1. By Value
5. Microarray
  1. By Value
By End User
1. Introduction
  1. End User By Value
2. Decentralized Laboratories
  1. By Value
3. Hospital
  1. By Value
4. Homecare
  1. By Value
5. Assisted Living Healthcare Facilities
  1. By Value
China
1. By Product Type
  1. Introduction
    1. Product Type By Value
  2. Analyzers
    1. By Value
  3. Test Kits
    1. By Value
  4. Reagents
    1. By Value
2. By Technology
  1. Introduction
    1. Technology By Value
  2. PCR
    1. By Value
  3. Genetic Sequencing
    1. By Value
  4. Hybridization
    1. By Value
  5. Microarray
    1. By Value
3. By End User
  1. Introduction
    1. End User By Value
  2. Decentralized Laboratories
    1. By Value
  3. Hospital
    1. By Value
  4. Homecare
    1. By Value
  5. Assisted Living Healthcare Facilities
    1. By Value
Korea
Japan
India
Australia
Taiwan
South East Asia
Rest of Asia-Pacific

Middle East and Africa Market Analysis

Introduction
By Product Type
1. Introduction
  1. Product Type By Value
2. Analyzers
  1. By Value
3. Test Kits
  1. By Value
4. Reagents
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. PCR
  1. By Value
3. Genetic Sequencing
  1. By Value
4. Hybridization
  1. By Value
5. Microarray
  1. By Value
By End User
1. Introduction
  1. End User By Value
2. Decentralized Laboratories
  1. By Value
3. Hospital
  1. By Value
4. Homecare
  1. By Value
5. Assisted Living Healthcare Facilities
  1. By Value
UAE
1. By Product Type
  1. Introduction
    1. Product Type By Value
  2. Analyzers
    1. By Value
  3. Test Kits
    1. By Value
  4. Reagents
    1. By Value
2. By Technology
  1. Introduction
    1. Technology By Value
  2. PCR
    1. By Value
  3. Genetic Sequencing
    1. By Value
  4. Hybridization
    1. By Value
  5. Microarray
    1. By Value
3. By End User
  1. Introduction
    1. End User By Value
  2. Decentralized Laboratories
    1. By Value
  3. Hospital
    1. By Value
  4. Homecare
    1. By Value
  5. Assisted Living Healthcare Facilities
    1. By Value
Turkey
Saudi Arabia
South Africa
Egypt
Nigeria
Rest of MEA

LATAM Market Analysis

Introduction
By Product Type
1. Introduction
  1. Product Type By Value
2. Analyzers
  1. By Value
3. Test Kits
  1. By Value
4. Reagents
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. PCR
  1. By Value
3. Genetic Sequencing
  1. By Value
4. Hybridization
  1. By Value
5. Microarray
  1. By Value
By End User
1. Introduction
  1. End User By Value
2. Decentralized Laboratories
  1. By Value
3. Hospital
  1. By Value
4. Homecare
  1. By Value
5. Assisted Living Healthcare Facilities
  1. By Value
Brazil
1. By Product Type
  1. Introduction
    1. Product Type By Value
  2. Analyzers
    1. By Value
  3. Test Kits
    1. By Value
  4. Reagents
    1. By Value
2. By Technology
  1. Introduction
    1. Technology By Value
  2. PCR
    1. By Value
  3. Genetic Sequencing
    1. By Value
  4. Hybridization
    1. By Value
  5. Microarray
    1. By Value
3. By End User
  1. Introduction
    1. End User By Value
  2. Decentralized Laboratories
    1. By Value
  3. Hospital
    1. By Value
  4. Homecare
    1. By Value
  5. Assisted Living Healthcare Facilities
    1. By Value
Mexico
Argentina
Chile
Colombia
Rest of LATAM

Competitive Landscape

Point-Of-Care Molecular Diagnostics Market Share By Players
M&A Agreements & Collaboration Analysis

Market Players Assessment

Abbott
1. Overview
2. Business Information
3. Revenue
4. ASP
5. SWOT Analysis
6. Recent Developments
Cepheid
Hemex Health
En Carta
Bayer AG
Hoffmann-La Roche AG
Nova Biomedical
QIAGEN
Nipro Diagnostics
Danaher
Bio-Rad Laboratories, Inc.
bioMérieux
Agilent Technologies, Inc.
Abaxis
OraSure Technologies
Waters Corporation
Aptitude Medical Systems
BD

Research Methodology

Research Data
1. Secondary Data
  1. Major secondary sources
  2. Key data from secondary sources
2. Primary Data
  1. Key data from primary sources
  2. Breakdown of primaries
3. Secondary And Primary Research
  1. Key industry insights
Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
3. Market Projection
Research Assumptions
1. Assumptions
Limitations
Risk Assessment